Loading
companiesCompany
JW Pharmaceutical
JW Pharmaceutical is a Seoul drug maker founded in 1945, known for intravenous fluids and nutrition, which sponsors phase 3 cancer trials among its hospital products.
Also called: JW Pharmaceutical CorporationJW중외제약
Overview
JW Pharmaceutical, headquartered in Seoul and founded in 1945 as Chungwae, is a Korean pharmaceutical company strong in intravenous solutions, parenteral nutrition and hospital medicines, with a research arm developing targeted drugs. ClinicalTrials.gov lists JW as lead sponsor of a phase 3 trial in a cancer setting. Its own cancer candidate on the registry is CWP232291, a Wnt pathway inhibitor tested in phase 1 and phase 1/2 trials in acute myeloid leukaemia, myelodysplastic syndromes and multiple myeloma (NCT01398462, NCT03055286, NCT02426723).
Similar pages
- CompanyVion Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanyCyclacel Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanySunesis Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanyPregLem
- CompanyAngiocrine Bioscience
Shares Pivotal (registrational) trial, Clinical trial, Multiple myeloma.
- CompanyCartesian Therapeutics
Shares Pivotal (registrational) trial, Clinical trial, Multiple myeloma.
- CompanyAgennix
- CompanyLisata Therapeutics